Abstract
Pityriasis rubra pilaris (PRP) is a rare papulosquamous skin condition
that affects both adults and the pediatric population. It is
characterized by salmon-colored plaques with islands of sparing and
palmoplantar hyperkeratosis. Currently, there are no established
guidelines for PRP treatment, especially in pediatric patients. In this
study, we presented an infant case of type III juvenile PRP successfully
treated with a short-term, low-dose cyclosporine A (CsA). No recurrence
occurred during the 3-month follow-up period after completing treatment.
Additionally, we reviewed the use of CsA as an alternative treatment
option for juvenile-onset PRP. The results of this study were consistent
with previous findings for adult-onset PRP. Therefore, this study
further supports using CsA as an alternative option for treating
juvenile-onset PRP.